Nilotinib 150mg is a prescription medication primarily used in the treatment of chronic myeloid leukaemia (CML), a type of cancer that affects the blood and bone marrow. This oral medication belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking specific proteins responsible for the growth and division of cancer cells.